Graf Akcie IDXX (Idexx Laboratories, Inc.). Diskuze k akciím IDXX. Aktuální informace IDXX.

Základní informace o společnosti Idexx Laboratories, Inc. (Akcie IDXX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 52.13B
Hodnota podniku (EV) 57.41B
Tržby 3.047B
EBITDA 963.472M
Zisk 727.848M
Růst v tržbách Q/Q 29.57 %
Růst v tržbách Y/Y 23.11 %
P/E (Cena vůči ziskům) 74.55
Forward P/E 0.62
EV/Sales 18.84
EV/EBITDA 59.58
EV/EBIT 66.44
PEG 5.96
Price/Sales 17.11
P/FCF 75.09
Price/Book 82.48
Účetní hodnota na akcii 7.70
Hotovost na akcii 4.68
FCF vůči ceně 1.33 %
Počet zaměstnanců 9,300
Tržba na zaměstnance 327.589k
Profit margin 21.49 %
Operating margin 28.35 %
Gross margin 58.04 %
EBIT margin 28.36 %
EBITDA margin 31.62 %
EPS - Zisk na akcii 8.52
EPS - Kvartální růst 36.05 %
EPS - Očekávaný růst příští rok 11.83 %
Return on assets 32.06 %
Return on equity 115.40 %
ROIC 33.68 %
ROCE 49.08 %
Dluhy/Equity 2.63
Čistý dluh/EBITDA 2.90
Current ratio 1.54
Quick Ratio 1.17
Volatilita 2.47
Beta 1.07
RSI 47.50
Cílová cena analytiků 477
Známka akcie (dle analytiků) 2.00
Insider ownership 0.96 %
Institutional ownership 88.03 %
Počet akcií 85.076M
Procento shortovaných akcií 1.67 %
Short ratio 3.26 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1991
Země United States

Finanční výsledky akcie IDXX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$2,706.655$2,406.908$2,213.242$1,969.058$1,775.423$1,601.892
Cost Of Goods Sold$1,135.615$1,041.359$971.7$871.676$799.987$711.622
Gross Profit$1,571.04$1,365.549$1,241.542$1,097.382$975.436$890.27
Research And Development Expenses$141.249$133.193$117.863$109.182$101.122$99.681
SG&A Expenses$735.267$679.51$632.344$575.172$524.075$482.465
Other Operating Income Or Expenses-----$-8.212
Operating Expenses$2,012.131$1,854.062$1,721.907$1,556.03$1,425.184$1,301.98
Operating Income$694.524$552.846$491.335$413.028$350.239$299.912
Total Non-Operating Income/Expense$-32.539$-30.628$-33.593$-31.971$-28.393$-26.771
Pre-Tax Income$661.985$522.218$457.742$381.057$321.846$273.141
Income Taxes$79.854$94.426$80.695$117.788$99.792$81.006
Income After Taxes$582.131$427.792$377.047$263.269$222.054$192.135
Other Income------
Income From Continuous Operations$582.131$427.792$377.047$263.269$222.054$192.135
Income From Discontinued Operations------
Net Income$581.776$427.72$377.031$263.144$222.045$192.078
EBITDA$790.522$640.857$574.513$496.168$429.3$370.3
EBIT$694.524$552.846$491.335$413.028$350.239$299.912
Basic Shares Outstanding858687889093
Shares Outstanding878888909194
Basic EPS$6.82$4.97$4.34$3.00$2.47$2.07
EPS - Earnings Per Share$6.71$4.89$4.26$2.94$2.44$2.05
# 2020 2019 2018 2017 2016 2015
Current Ratio1.82360.9370.84910.96760.90480.959
Long-term Debt / Capital0.57570.79721.01561.09751.22321.1637
Debt/Equity Ratio1.43575.5542-108.338-23.4218-11.1272-13.9304
Gross Margin58.043656.734656.096155.731354.941155.5762
Operating Margin25.659922.969122.199820.975919.727118.7224
EBIT Margin25.659922.969122.199820.975919.727118.7224
EBITDA Margin29.206626.625725.95825.198224.180223.1164
Pre-Tax Profit Margin24.457721.696620.68219.352318.127917.0512
Net Profit Margin21.494317.770517.035213.36412.506611.9907
Asset Turnover1.17961.31351.43961.14921.15991.086
Inventory Turnover Ratio5.4115.33985.60695.30485.06213.7685
Receiveable Turnover8.16668.93728.89378.39348.6828.5063
Days Sales In Receivables44.694140.840341.040343.486742.040942.9093
ROE - Return On Equity91.9936240.5693-4083.647-488.9667-205.2009-228.7456
Return On Tangible Equity172.7879-355.4063-141.9888-88.4756-66.7639-60.261
ROA - Return On Assets25.3723.34524.525815.365214.506713.0262
ROI - Return On Investment39.035548.793863.67847.673545.794137.4466
Book Value Per Share7.40552.0805-0.1072-0.6181-1.2301-0.9333
Operating Cash Flow Per Share2.22790.72270.35470.43821.3610.0449
Free Cash Flow Per Share2.76470.2609-0.12320.32061.5335-0.2975

Porovnání s konkurencí: Akcie IDXX

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
IDXX 74.55 5.96 23.11 % 11.83 % 115.40 % 82.48 21.49 %
Akcie ABT 32.91 2.96 27.95 % -5.10 % 19.26 % 6.29 12.99 %
Akcie HSIC 24.35 2.44 28.06 % -9.71 % 18.33 % 3.36 3.99 %
Akcie HSKA N/A N/A 74.29 % -64.91 % -0.41 % 9.10 -7.30 %
Akcie NEOG 71.33 2.97 14.40 % 6.67 % 7.57 % 5.24 13.00 %
Akcie TMO 26.53 7.52 45.73 % -18.29 % 24.87 % 6.60 19.79 %
Akcie VIVO 11.18 1.41 27.24 % 120.00 % 24.61 % 3.24 18.21 %

Nedávné obchody insiderů: Akcie IDXX

Jméno Obchod Cena Objem
Michael Lane
Executive Vice President
Option
14 Feb 2021
$544.08 $535,375
Jonathan Jay Mazelsky
President and CEO
Option
14 Feb 2021
$544.08 $1,692,089
Brian P Mckeon
Executive VP and CFO
Option
14 Feb 2021
$544.08 $1,437,459
James F Polewaczyk
Executive Vice President
Option
14 Feb 2021
$544.08 $538,095
Kathy V Turner
Senior Vice President
Option
14 Feb 2021
$544.08 $537,007
Giovani Twigge
Senior Vice President
Option
14 Feb 2021
$544.08 $612,634
Sharon E. Underberg
SVP, Gen. Counsel, and Secretary
Option
14 Feb 2021
$544.08 $380,856
Bruce L. Claflin
Director
Prodej
16 Feb 2021
$536.91 $3,936,087
Jonathan Jay Mazelsky
President and CEO
Option
17 Feb 2021
$52.00 $1,300,000
Brian P Mckeon
Executive VP and CFO
Option
18 Feb 2021
$67.85 $100,011
Jonathan W Ayers
Director
Option
18 Feb 2021
$79.54 $79,540

Diskuze k akciím IDXX